Prior exposure to endotoxin exacerbates lipopolysaccharide-induced hypoxemia and alveolitis in anesthetized swine

Shock. 1994 Nov;2(5):362-9. doi: 10.1097/00024382-199411000-00011.

Abstract

We sought to determine whether a standardized "priming" event, namely a small dose of LPS, would alter physiological responses to a subsequent larger "challenge" dose of endotoxin. Accordingly, four groups of pigs (N = 5-6) were studied. One group received neither priming nor challenge doses of LPS. A second group were not primed but were infused with a challenge dose (250 micrograms/kg) of LPS. A third group were pretreated 18 h before being studied with a priming dose of LPS (20 micrograms/kg), but were not infused with a second dose of LPS. A fourth group received both priming and challenge doses of LPS. Priming with LPS exacerbated endotoxin-induced arterial hypoxemia, and decreased animal-to-animal variability in the degree of hypoxemia induced by a challenge dose of endotoxin. Priming blunted the early phase (30 min) and exacerbated the delayed phase (120-210 min) of LPS-induced pulmonary hypertension. Priming blunted LPS-induced release of prostacyclin and thromboxane A2. The use of a priming dose of LPS increases the severity and reproducibility of LPS-induced acute lung injury in swine.

Publication types

  • Comparative Study

MeSH terms

  • 6-Ketoprostaglandin F1 alpha / blood
  • Animals
  • Blood Pressure
  • Bronchoalveolar Lavage Fluid
  • Cardiac Output
  • Drug Administration Schedule
  • Endotoxins / administration & dosage
  • Endotoxins / toxicity*
  • Hypoxia / blood
  • Hypoxia / chemically induced
  • Hypoxia / physiopathology*
  • Lipopolysaccharides / administration & dosage
  • Lipopolysaccharides / toxicity*
  • Male
  • Oxygen / blood
  • Partial Pressure
  • Premedication
  • Pulmonary Fibrosis / blood
  • Pulmonary Fibrosis / physiopathology*
  • Shock, Septic / blood
  • Shock, Septic / physiopathology*
  • Swine
  • Thromboxane B2 / blood
  • Time Factors
  • Tumor Necrosis Factor-alpha / analysis
  • Vascular Resistance

Substances

  • Endotoxins
  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha
  • Thromboxane B2
  • 6-Ketoprostaglandin F1 alpha
  • Oxygen